American International Group Inc vs Mesoblast Limited — how do they compare? American International Group Inc trades at $77.45 (market cap $40.42B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: American International Group Inc is far larger — about 18.3× Mesoblast Limited's market cap, and American International Group Inc pays a 2.59% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| AIG | MESO | |
|---|---|---|
Market Cap | $40.42B | $2.21B |
Sector | Financials | Technology |
52-Week High | $86.59 | $20.96 |
52-Week Low | $71.89 | $12.88 |
Enterprise Value | $48.06B | $2.21B |
Dividend Yield | 2.59% | — |
Trailing returns across standard periods
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.
Read more on AIG →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →